Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose intravenous N-acetylcysteine versus iloprost for early rapidly progressive systemic scleroderma skin fibrosis
2006-003957-25Phase 3Active
- Sponsor
- Azienda Ospedaliero-Universitaria delle Marche
- Start
- Jul 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in systemic sclerosis (SSc) and scleredema comparing High-dose intravenous N-acetylcysteine with Intravenous iloprost (2 arms). Primary endpoint: Change in skin thickness by modified Rodnan skin score. Started Jul 2007; status: active.
02
Drugs
acetylcysteineiloprost
03
Conditions
systemic sclerosis (SSc)scleredema
Beyond the preview
Go deeper on 2006-003957-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003957-25.